Concepedia

Douglas Logan

DL

Statistics

Publications

10

Citations

1.3K

H-Index

10

Active since

1986

Affiliations

Medpace (United States)(Current)

VA San Diego Healthcare System

University of California San Diego

University of Florida

Intarcia Therapeutics (United States)

Douglas Logan is an author at Medpace (United States) specializing in medicine, pharmacology, and cardiovascular disease.

Top concepts

Publications per year

1986–2017

10

Publications

10

Effect of a Monoclonal Antibody to PCSK9 on LDL Cholesterol

Evan A. Stein, Scott Mellis, George D. Yancopoulos et al. · New England Journal of Medicine · 2012 · 659 citations · Full text

Enteric Coating and Aspirin Nonresponsiveness in Patients With Type 2 Diabetes Mellitus

Deepak L. Bhatt, Jing-fei Dong, Douglas Logan et al. · Journal of the American College of Cardiology · 2017 · 146 citations

, , +4

The Influence of Smoking Status on the Pharmacokinetics and Pharmacodynamics of Clopidogrel and Prasugrel

Paul A. Gurbel, Kevin P. Bliden, Douglas Logan et al. · Journal of the American College of Cardiology · 2013 · 137 citations

, , +9

Recovery of Platelet Function After Discontinuation of Prasugrel or Clopidogrel Maintenance Dosing in Aspirin-Treated Patients With Stable Coronary Disease

Matthew J. Price, James Walder, Brian Baker et al. · Journal of the American College of Cardiology · 2012 · 115 citations

, , +12

Continuous subcutaneous delivery of exenatide via ITCA 650 leads to sustained glycemic control and weight loss for 48 weeks in metformin-treated subjects with type 2 diabetes

Robert R. Henry, Julio Rosenstock, Douglas Logan et al. · Journal of Diabetes and its Complications · 2014 · 79 citations · Full text

1–5 of 10